Xtandi Европейский союз - итальянский - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - neoplasie prostatiche - terapia endocrina - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

SERENASE Италия - итальянский - AIFA (Agenzia Italiana del Farmaco)

serenase

istituto luso farmaco d'italia s.p.a. - aloperidolo - aloperidolo

MANTADAN Италия - итальянский - AIFA (Agenzia Italiana del Farmaco)

mantadan

hikma farmaceutica (portugal) s.a. - amantadina - amantadina